A detailed history of Sargent Bickham Lagudis LLC transactions in Embecta Corp. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 86 shares of EMBC stock, worth $1,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86
Previous 86 -0.0%
Holding current value
$1,606
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$24.0 - $33.42 $840 - $1,169
-35 Reduced 28.93%
86 $3,000
Q2 2022

Jul 13, 2022

BUY
$24.78 - $33.36 $2,998 - $4,036
121 New
121 $3,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.08B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.